Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Research 68, 627-630, February 1, 2008. doi: 10.1158/0008-5472.CAN-07-2704
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Urosevic, M.
Right arrow Articles by Dummer, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urosevic, M.
Right arrow Articles by Dummer, R.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Inflammation and Immune Escape
Right arrow Cancer Immunology: Innate Immunity

Reviews

Human Leukocyte Antigen–G and Cancer Immunoediting

Mirjana Urosevic and Reinhard Dummer

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Requests for reprints: Mirjana Urosevic, Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland. Phone: 41-44-255-11-11; Fax: 41-44-255-44-18; E-mail: mirjana.urosevic{at}usz.ch.

Key Words: HLA-G • cancer immunoediting • immunescape • immunosurveillance

Immunosurveillance is an extrinsic mechanism of cancer suppression that eliminates nascent tumors. However, the selection imposed by immunosurveillance can drive tumor evolution and the emergence of clinically apparent neoplasms. Mechanisms of immune escape acquired by less immunogenic variants during this process, termed immunoediting, may contribute significantly to malignant progression. In this review, we summarize the evidence that up-regulation of the nonclassic human leukocyte antigen (HLA) class I molecule HLA-G in tumor cells plays an important role in cancer and immune escape. [Cancer Res 2008;68(3):627–30]




This article has been cited by other articles:


Home page
CRO ContentHome page
G. C. Prendergast
Murder or Suicide: Strategies to Selectively Eliminate Cancer Cells
Cancer Reviews Online Content, March 1, 2008; 2008(3): 5 - 6.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.